Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
doi:10.1001/jamadermatol.2014.1348 2
GLP-1 Receptor Agonist Market Segmentation By Product Outlook (Revenue, USD Billion, 20212034) Ozempic Trulicity Mounjaro Wegovy Rybelsus Saxenda Victoza Zepbound Others By Application Outlook (Revenue, USD Billion, 20212034) Type 2 Diabetes Mellitus Obesity By Route of Administration Outlook (Revenue, USD Billion, 20212034) Parenteral Oral By Distribution Channel Outlook (Revenue, USD Billion, 20212034) Hospital Pharmacies Retail Pharmacies Online Pharmacies By Regional Outlook (Revenue, USD Billion, 20212034) North America US Canada Europe Germany France UK Italy Spain Netherlands Russia Rest of Europe Asia Pacific China Japan India Malaysia South Korea Indonesia Australia Vietnam Rest of Asia Pacific Middle East & Africa Saudi Arabia UAE Israel South Africa Rest of Middle East & Africa Latin America Mexico Brazil Argentina Rest of Latin America GLP-1 Receptor Agonist Market Report Scope Source: Polaris Market Research Analysis GLP-1 Receptor Agonist Market FAQ's The global market size was valued at USD 61.89 billion in 2025 and is projected to grow to USD 257.12 billion by 2034
Packaging should be set up to match clinical study procedures or commercial dispensing models
Epigenetic modulation of DNA methylation by nutrition and its mechanisms in animals
The legal vulnerability of the Arkansas law is ERISA preemption: self-insured employer benefit plans governed by ERISA may argue that the state law impermissibly regulates the terms of an employee benefit plan, a federal preemption argument that has successfully challenged multiple state PBM regulations in prior litigation
US$ 28.95
US$ 24.82
US$ 21.71
US$ 29.54
US$ 25.06
US$ 29.68
US$ 25.53
US$ 21.69
US$ 21.85
US$ 27.30
US$ 22.04
US$ 26.05
